2023
DOI: 10.1093/brain/awad060
|View full text |Cite|
|
Sign up to set email alerts
|

Multimodal mapping of regional brain vulnerability to focal cortical dysplasia

Abstract: Focal cortical dysplasia (FCD) type II is a highly epileptogenic developmental malformation and a common cause of surgically treated drug-resistant epilepsy. While clinical observations suggest frequent occurrence in the frontal lobe, mechanisms for such propensity remain unexplored. Here, we hypothesized that cortex-wide spatial associations of FCD distribution with cortical cytoarchitecture, gene expression and organizational axes may offer complementary insights into processes that predispose given cortical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 112 publications
0
4
0
Order By: Relevance
“…47 Spatially-embedded gene expression atlases of the adult human 35,68 and mouse 70,161 have proven exceptionally powerful in recent years, bridging resolution gaps to common neuroimaging modalities 162,163 and providing insight into the molecular correlates of structural 26,42,164 and functional neuroanatomy, 36,165,166 brain development, [167][168][169] disease and disorder. 47,170,171 In such studies, comparisons with in vivo neuroanatomy can only be fully realised through threedimensional localisation of tissue samples within a common coordinate space. 62,68,70 To date, a limitation of this approach has been either the sampling of a narrow age range outside of key developmental periods 35,69 or, in developmental datasets, a lack of 3D spatial information 3 and relatively coarse anatomical sampling.…”
Section: Discussionmentioning
confidence: 99%
“…47 Spatially-embedded gene expression atlases of the adult human 35,68 and mouse 70,161 have proven exceptionally powerful in recent years, bridging resolution gaps to common neuroimaging modalities 162,163 and providing insight into the molecular correlates of structural 26,42,164 and functional neuroanatomy, 36,165,166 brain development, [167][168][169] disease and disorder. 47,170,171 In such studies, comparisons with in vivo neuroanatomy can only be fully realised through threedimensional localisation of tissue samples within a common coordinate space. 62,68,70 To date, a limitation of this approach has been either the sampling of a narrow age range outside of key developmental periods 35,69 or, in developmental datasets, a lack of 3D spatial information 3 and relatively coarse anatomical sampling.…”
Section: Discussionmentioning
confidence: 99%
“…We calculated the enrichment ratio (ER) for each PLS component. The ER is defined as the difference between the mean bootstrap weight of the candidate gene and the mean bootstrap weight of the same number of randomly permuted genes, which was further divided by the standard deviation weight of the permuted genes 35 . Significance was determined by the percentile of the bootstrap weight of the candidate genes relative to the bootstrap weights of randomly selected genes from 10,000 permutations.…”
Section: Specificity Analysismentioning
confidence: 99%
“…3 A large recent multicenter study of 337 patients with FCD type II used multimodal mapping to show a preferential lesion location to the frontal lobe, and found FCD transcriptomic associations with prenatal neuroglial and proliferation genes, as well as genes related to postnatal synaptogenesis and circuit development. 6 Despite the localized nature of histopathological abnormalities in FCD, and often normal-appearing cortex elsewhere, there is ample evidence for considering FCD-related epilepsy a network disease. [7][8][9] This network-based pathogenesis model is not limited to FCD; however, not all cortical lesions show the same epileptogenesis potential and person-to-person variability in network involvement.…”
Section: Introductionmentioning
confidence: 99%
“…There is a growing literature in the understanding of the genetic basis of FCD, with evidence for postnatal somatic mutations that associate FCD types IIA and IIB with the mammalian target of rapamycin (mTOR) pathway, FCD type III with the mitogen‐activated protein kinase (MAPK) pathway, and FCD type I with glysolyation 5 as well as transcriptomic errors 3 . A large recent multicenter study of 337 patients with FCD type II used multimodal mapping to show a preferential lesion location to the frontal lobe, and found FCD transcriptomic associations with prenatal neuroglial and proliferation genes, as well as genes related to postnatal synaptogenesis and circuit development 6 …”
Section: Introductionmentioning
confidence: 99%